Shanghai Fosun Pharmaceutical (Group) (SFOSF) Stock Price, News & Analysis

Company Overview

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Key Stats

• Today's Range: $1.95 to $1.95
• 50-Day Range: $1.88 to $2.01
• 52-Week Range: $1.50 to $2.24
• Volume: N/A
• Average Volume: 5,080 shs
• Market Capitalization: N/A
• P/E Ratio: 1.66
• Dividend Yield: 13.88%
• Price Target: N/A
• Consensus Rating: N/A

SFOSF Stock Analysis - Frequently Asked Questions

How have SFOSF shares performed this year?

Shanghai Fosun Pharmaceutical (Group)'s stock was trading at $1.8003 at the beginning of the year. Since then, SFOSF stock has increased by 8.0% and is now trading at $1.9450.
View the best growth stocks for 2025 here.

How do I buy shares of Shanghai Fosun Pharmaceutical (Group)?

Shares of SFOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 4/20/2025
• Next Earnings (Estimated): 4/28/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SFOSF
• CIK: N/A
• Web: www.fosunpharma.com
• Phone: 86-21-3398-7000
• Fax: N/A
• Employees: 40,370
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 1.66
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A